:format(jpeg):focal(587x93:597x83)/cloudfront-us-east-1.images.arcpublishing.com/gfrmedia/K3ZPJTSCVRGJTMWX7BMMOICX7Q.jpg)
Over six million people in the United States suffer from atrial fibrillation (AF) and by 2030 it is expected to double that number. It is a condition that, when untreated, is the cause of more than half of brain infarctions.
Today, however, there are minimally invasive alternatives that offer a wide range of quality of life to patients through the use of the WATCHMAN cardiac device, a permanent implant designed to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AF). ANDThe procedure already has over 200 successful implants performed in the St. Luke’s Episcopal Medical Centerthe first hospital in Puerto Rico to implement the device, according to the institution in a press release.
Atrial fibrillation, or atrial fibrillation, is a cardiac arrhythmia one of the most common that exists where the heart behaves irregularly, causing clots that can lead to a stroke. “People who suffer symptoms of palpitations, shortness of breath, chest pain, increased heart rate or dizziness should evaluate their origin to identify if they suffer from AF,” recommend the experts at the San Lucas Episcopal Medical Center.
According to the information, the initial treatment to avoid brain infarction in atrial fibrillation is the use of anticoagulants. However, it is indicated that there are patients who cannot use anticoagulants due to bleeding problems or because of professions with a high risk of trauma that trigger bleeding. “These patients are ideal candidates to receive an implant with WATCHMAN™. The device is inserted through the groin and brought to the heart. Once installed, it covers the left atrium appendage in a minimally invasive way and prevents brain infarctions due to clots.”
“Patients with atrial fibrillation are five times more at risk than a person who does not have the condition of suffering a stroke. Watchman is a great tool as a device conceptualized to close the left atrium appendage where more than 90 to 95% of clots form in the heart. In patients with atrial fibrillation these can trigger a brain infarction. The use of Watchman allows you to eliminate the use of anticoagulant and its side effects. Since we started in 2016, it has been of great benefit to patients who have had the opportunity to have this treatment alternative for the prevention of stroke and improve their quality of life,” said Dr. Jose Roman Ramos, invasive cardiologist, in the statement. from the San Lucas Episcopal Medical Center.
exist Risk factors that cause a predisposition in the patient include high blood pressure, obesity, diabetes, smoking, sleep apnea, alcohol consumption and genetic factors. “Patients can benefit from a procedure that has demonstrated a 98.8% success rate. Only 0.5% have resulted in adverse events as a result of device use.”
In Puerto Rico, 770 patients have already had the device successfully implanted. “The Watchman means the future of anticoagulation, which is exactly that, not anticoagulation. We are going to see that with new studies coming in the future such as the Champion A Fib, we are already seeing the possibility of replacing anticoagulation with the device. Currently the indications are for patients who have a contraindication for long-term anticoagulation,” added electrophysiologist Francisco Perez-Gil. “Watchman is going to fill that gap that existed for thousands and thousands of patients who had no other treatment options,” he added.
According to the statement, Watchman has been implanted in more than 300,000 patients globally and is performed in a single procedure. The device is permanent, does not have to be replaced and cannot be seen outside the body. The procedure often leads to patients spending the night in the hospital returning home the next day.
For more information about WATCHMAN™, features, procedure, advantages and risks you can visit www.watchmanpr.com.
